COVID-19 vaccine could be available in early 2021; EDB pumps in US$200m

Arcturus Therapeutics Duke-NUS Covid-19 Vaccine

A COVID-19 vaccine co-developed by Duke-NUS Medical School and Arcturus Therapeutics could be available in Singapore in the first quarter of 2021. Arcturus Therapeutic, which is based in California, made the announcement on 9 November. The vaccine is currently undergoing Phase 1/2 clinical trial in Singapore. This phase studies the safety and side effects of […]